BIOMAT Database Logo BIOMAT Database Logo

Determination of cathepsins B and H in sera and synovial fluids of patients with different joint diseases. 1990

D Gabrijelcic, and A Annan-Prah, and B Rodic, and B Rozman, and V Cotic, and V Turk
Department of Biochemistry, J. Stefan Institute, Ljubljana, Yugoslavia.

Synovial fluids and sera of patients with inflammatory and metabolic joint diseases contain different cysteine proteinases. The quantities of cathepsins B and H were determined by newly developed specific enzyme-linked immunoassay tests (ELISA), with detection limits of 0.5 microgram/l for cathepsin B and 3 micrograms/l for cathepsin H. The values of cathepsin B in normal sera ranged from 0.6 microgram/l to 2 micrograms/l, whereas in sera of patients with joint diseases they ranged from 1.7 micrograms/l to 18 micrograms/l. Cathepsin H was not found in sera (values below 3 micrograms/l), but was measurable in patients' synovial fluids. Patients with rheumatoid arthritis have on average the highest values of cathepsin B in synovial fluids, whereas patients with undifferentiated arthritis have the highest values of cathepsin H. The results show that cathepsins B and H are present in arthritic synovial fluids, where they may be implicated in destructive processes. There is yet no clear correlation between the quantity of each cathepsin released in synovia and the clinical diagnosis or the stage of the disease.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007592 Joint Diseases Diseases involving the JOINTS. Arthropathies,Arthropathy,Joint Disease
D007704 Kininogens Endogenous peptides present in most body fluids. Certain enzymes convert them to active KININS which are involved in inflammation, blood clotting, complement reactions, etc. Kininogens belong to the cystatin superfamily. They are cysteine proteinase inhibitors. HIGH-MOLECULAR-WEIGHT KININOGEN; (HMWK); is split by plasma kallikrein to produce BRADYKININ. LOW-MOLECULAR-WEIGHT KININOGEN; (LMWK); is split by tissue kallikrein to produce KALLIDIN. Cystatins, Kininogen,Kininogen,Prekinins,Prokinins,T-Kininogen,Thiostatin,Kininogen Cystatins,T Kininogen
D002401 Cathepsin B A lysosomal cysteine proteinase with a specificity similar to that of PAPAIN. The enzyme is present in a variety of tissues and is important in many physiological and pathological processes. In pathology, cathepsin B has been found to be involved in DEMYELINATION; EMPHYSEMA; RHEUMATOID ARTHRITIS, and NEOPLASM INVASIVENESS. Cathepsin B-Like Proteinase,Cathepsin B1,Cathepsin B Like Proteinase,Proteinase, Cathepsin B-Like
D002403 Cathepsins A group of lysosomal proteinases or endopeptidases found in aqueous extracts of a variety of animal tissues. They function optimally within an acidic pH range. The cathepsins occur as a variety of enzyme subtypes including SERINE PROTEASES; ASPARTIC PROTEINASES; and CYSTEINE PROTEASES. Cathepsin
D003546 Cysteine Endopeptidases ENDOPEPTIDASES which have a cysteine involved in the catalytic process. This group of enzymes is inactivated by CYSTEINE PROTEINASE INHIBITORS such as CYSTATINS and SULFHYDRYL REAGENTS.
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis

Related Publications

D Gabrijelcic, and A Annan-Prah, and B Rodic, and B Rozman, and V Cotic, and V Turk
Determination of interferon in sera and synovial fluids in different rheumatic diseases.
August 1987, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
D Gabrijelcic, and A Annan-Prah, and B Rodic, and B Rozman, and V Cotic, and V Turk
Soluble urate in sera and synovial fluids from patients with different joint disorders.
January 1996, Clinical and experimental rheumatology,
D Gabrijelcic, and A Annan-Prah, and B Rodic, and B Rozman, and V Cotic, and V Turk
Immunochemical quantitation of complement components of Clq and C3 in sera and synovial fluids of patients with bone and joint diseases.
June 1980, Annals of the rheumatic diseases,
D Gabrijelcic, and A Annan-Prah, and B Rodic, and B Rozman, and V Cotic, and V Turk
Determination of cathepsins B, H, L and kininogen in breast cancer patients.
January 1992, Agents and actions. Supplements,
D Gabrijelcic, and A Annan-Prah, and B Rodic, and B Rozman, and V Cotic, and V Turk
Ferritin subunits in sera and synovial fluids from patients with rheumatoid arthritis.
December 1998, The Journal of rheumatology,
D Gabrijelcic, and A Annan-Prah, and B Rodic, and B Rozman, and V Cotic, and V Turk
Different immunolocalizations of cathepsins B, H, and L in the liver.
November 1985, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society,
D Gabrijelcic, and A Annan-Prah, and B Rodic, and B Rozman, and V Cotic, and V Turk
Cathepsins B and L in synovial fluids from patients with rheumatoid arthritis and the effect of cathepsin B on the activation of pro-urokinase.
February 2000, The journal of medical investigation : JMI,
D Gabrijelcic, and A Annan-Prah, and B Rodic, and B Rozman, and V Cotic, and V Turk
Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients.
October 1997, Clinical cancer research : an official journal of the American Association for Cancer Research,
D Gabrijelcic, and A Annan-Prah, and B Rodic, and B Rozman, and V Cotic, and V Turk
Active cathepsins B, H, K, L and S in human inflammatory bronchoalveolar lavage fluids.
January 2006, Biology of the cell,
D Gabrijelcic, and A Annan-Prah, and B Rodic, and B Rozman, and V Cotic, and V Turk
Proceedings: Incidence of cathepsin D agglutinators in sera, synovial fluids, and exudate cells and synovial tissue of patients with RA and other rheumatic diseases.
April 1975, Annals of the rheumatic diseases,
Copied contents to your clipboard!